Global Psychedelic Drugs Market is Expected to Grow at CAGR of 13.3% in the Forecast Period of 2022 to 2029

The Global Psychedelic Drugs Market is growing with factors such as increases prevalence of depression and mental disorders, increased research activities in the field of psychedelic medicine and increased treatment options for people suffering from depression and mental disorder. However, regulations imposed on psychedelic drugs may obstruct the growth of the market in the given forecast period.

Global Psychedelic Drugs Market Scenario                             

According to Data Bridge Market Research, the market for psychedelic drugs in North America region has the highest market share in psychedelic drugs market. Market leader is Jazz Pharmaceutical, Inc. which accounts an estimated market share of approximately 70%. The company has gained outstanding sale through providing products that are used in psychedelic treatment.

  • In January 2020, Jazz Pharmaceuticals, Inc., presented a new drug application (NDA) for JZP-258, a novel product of Oxybet, which has 1000 to 1500 mg less sodium than Xyrem and is highly used with narcolepsy and cataplexy. Kindness is used to treat sleep. This submission will increase the company's footprint in the US market as it is a novel product and will increase revenue if approved

Psychedelic Drugs MarketTrends Impacting the Market

Now the question is which other regions Jazz Pharmaceutical, Inc. and Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.), Pfizer Inc. are targeting? Data Bridge Market Research has estimated a large growth in North America psychedelic drugs market and the market leaders targeting U.S., Canada and Mexico to be their next revenue pockets for 2022.

The psychedelic drugs market is becoming more competitive with companies such as Jazz Pharmaceutical, Inc. and Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.), Pfizer Inc. as they are the top dominating companies in psychedelic drugs having maximum number of products for treatment of psychedelic disorders. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the global psychedelic drugs market.

For more analysis on the global psychedelic drugs market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-psychedelic-drugs-market

Global Psychedelic Drugs Market Development

  • In July 2020, Jazz Pharmaceuticals, Inc. announced that it has received FDA approval for its Xywav oral solution for the treatment of excessive daytime sleepiness. The product is an oxybate product with unique composition of cations resulting in 92% less sodium. This has helped the company to increase its product portfolio.

Scope of the Global Psychedelic Drugs Market

The global psychedelic drugs market is segmented into five regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The regions are further segmented into major countries such as the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Belgium, Lithuania, Rest of Europe, India, Australia, South Korea, Singapore, Malaysia, Saudi Arabia, Israel, Egypt, U.A.E, South Africa, Rest of Middle East and Africa, Brazil, Argentina & Rest of South America. All country-based analysis of global psychedelic drugs market is further analyzed based on further segmentation.

Global psychedelic drugs market, by source (synthetic, natural), type (empathogens, dissociatives, others), drugs (child gamma-hydroxybutyric acid, ketamine, psilocybin, others), application (narcolepsy, treatment resistant depression, major depressive disorder, opiate addiction, post-traumatic stress disorder, others) route of administration (oral, inhalation, injectables) end user (hospitals, specialty clinics, homecare and others), distribution channel (hospital pharmacy, retail pharmacy, online pharmacy), By Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)- Industry Trends and Forecast to 2029.

To know more about the study https://www.databridgemarketresearch.com/reports/global-psychedelic-drugs-market

Key Pointers Covered in Global Psychedelic Drugs Market and Forecast to 2029

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries
  • Market value and over view of psychedelic drugs market
  • Company profiling of top eight players of psychedelic drugs market

Key Market Competitors Covered in the Report

  • Jazz Pharmaceuticals, Inc.
  • Janssen Pharmaceuticals, Inc. (A Subsidiary of Johnson & Johnson Services, Inc.)
  • Pfizer Inc.
  • Verrian
  • Avadel
  • Celon Pharma S.A.
  • COMPASS
  • F. Hoffmann-La Roche Ltd
  • Hikma Pharmaceuticals PLC
  • NeuroRx, Inc.
  • PharmaTher Inc.
  • usonainstitute.org
  • Mind Medicine, Inc.
  • Cybin Corp.
  • GABA Therapeutics, Inc.
  • EmpathBio
  • DemeRx

Above are the key players covered in the report, to know about more and exhaustive list of psychedelic drugs market companies’, contact us https://www.databridgemarketresearch.com/toc/?dbmr=global-psychedelic-drugs-market

Research Methodology: Global Psychedelic Drugs Market.

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Chief Level Officers, Product and Marketing Manager, Distributors, Buyers.
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/